No Data
US Stock MarketDetailed Quotes
AZNCF ASTRAZENECA
Watchlist
125.000
-3.500-2.72% Close 12/01 16:00 ET
131.740High125.000Low3.43KVolume
131.740Open128.500Pre Close440.69KTurnover0.00%Turnover Ratio33.07P/E (TTM)193.74BMarket Cap153.10052wk High59.24P/E (Static)1.55BShares120.60052wk Low5.21P/B193.74BFloat Cap153.100Historical High2.88Dividend TTM1.55BShs Float101.623Historical Low2.30%Div YieldTTM5.25%Amplitude128.517Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About ASTRAZENECA Company
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Revenue Breakdown
Business
Currency:USD
2022/12/31
Stock NameRevenueRatio
Pharmaceuticals44.35B100.00%
News
Laryngeal Cancer Therapeutics Market Size to Grow by USD 575.25 Million From 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and More Among the Major Companies in the Market- Technavio
The Laryngeal Cancer Therapeutics Market size is expected to grow by USD 575.25 million, accelerating at a CAGR of almost 5.43% during the forecast...
AstraZeneca Stops Two Lokelma Late-Stage Trials After Evaluating Potential Benefits
AstraZeneca Plc (NASDAQ:AZN) discontinued the STABILIZE-CKD and DIALIZE-Outcomes Phase 3 evidence trials for Lokelma (sodium zirconium cyclosilicate). The decision was made due to substantially incre
AstraZeneca Pulls Plug on Anti-hyperkalaemia Drug Trials
Comments
Stocks making the biggest moves in premarket trading:
$ASTRAZENECA(AZNCF.US$
— Shares rose 1.4% after Jefferies upgraded the stock to buy from hold. The upgrade comes after one of its breast cancer therapies, in joint development with Daiichi Sankyo, came out with positive results in a late-stage trial on Friday.
$Urban Outfitters(URBN.US$, $Foot Locker(FL.US$
— Shares of Urban Outfitters fell 4%, while Foot Locker slid 2.9% before the bell after Jefferies downgraded the stocks to hold from...
— Shares rose 1.4% after Jefferies upgraded the stock to buy from hold. The upgrade comes after one of its breast cancer therapies, in joint development with Daiichi Sankyo, came out with positive results in a late-stage trial on Friday.
$Urban Outfitters(URBN.US$, $Foot Locker(FL.US$
— Shares of Urban Outfitters fell 4%, while Foot Locker slid 2.9% before the bell after Jefferies downgraded the stocks to hold from...
2
Stocks making the biggest moves premarket:
$ASTRAZENECA(AZNCF.US$
— Shares of the British pharmaceutical company gained more $Wayfair(W.US$ than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer.
$Wayfair(W.US$
— Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue growth and margin commentary.
Chinese e-commer...
— Shares of the British pharmaceutical company gained more $Wayfair(W.US$ than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer.
$Wayfair(W.US$
— Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue growth and margin commentary.
Chinese e-commer...
5
ColumnsToday's Pre-Market Stock Movers And Top Ratings: INTC, PG, NYCB, XPEV and More
Pre-Market Stock Movers
Gapping up
$Intel(INTC.US$
(Shares popped 6.7% after the chipmaker posted better-than-expected second-quarter results and a return to profitability after two consecutive losing periods. Intel’s forecast for the third quarter also came in above analyst expectations. The company reported adjusted earnings of 13 cents a share on revenues of $12.95 billion.)
$Roku Inc(ROKU.US$
(The streaming stock...
Gapping up
$Intel(INTC.US$
(Shares popped 6.7% after the chipmaker posted better-than-expected second-quarter results and a return to profitability after two consecutive losing periods. Intel’s forecast for the third quarter also came in above analyst expectations. The company reported adjusted earnings of 13 cents a share on revenues of $12.95 billion.)
$Roku Inc(ROKU.US$
(The streaming stock...
21
2
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--